Molecular interactions of salvinorin a at the kappa opioid receptor.

被引：0
|
作者：
Kane, BE
McCurdy, CR
Ferguson, DM
机构：
[1] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Mississippi, Dept Med Chem, University, MS 38677 USA
[3] Univ Mississippi, Lab Appl Drug Design & Synth, University, MS 38677 USA
[4] Univ Minnesota, Minneapolis, MN 55455 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 227卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
273-MEDI
引用
收藏
页码：U57 / U57
页数：1
相关论文
共 50 条
  • [41] Asymmetric synthesis of salvinorin A, a potent κ opioid receptor agonist
    Scheerer, Jonathan R.
    Lawrence, Jonathan F.
    Wang, Grace C.
    Evans, David A.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (29) : 8968 - +
  • [42] Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor
    Polepally, Prabhakar R.
    Huben, Krzysztof
    Vardy, Eyal
    Setola, Vincent
    Mosier, Philip D.
    Roth, Bryan L.
    Zjawiony, Jordan K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 85 : 818 - 829
  • [43] Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
    Christina L. Nemeth
    Tracie A. Paine
    Joseph E. Rittiner
    Cécile Béguin
    F. Ivy Carroll
    Bryan L. Roth
    Bruce M. Cohen
    William A. Carlezon
    Psychopharmacology, 2010, 210 : 263 - 274
  • [44] Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening
    Puls, Kristina
    Olive-Marti, Aina-Leonor
    Hongnak, Siriwat
    Lamp, David
    Spetea, Mariana
    Wolber, Gerhard
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13788 - 13801
  • [45] Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
    Nemeth, Christina L.
    Paine, Tracie A.
    Rittiner, Joseph E.
    Beguin, Cecile
    Carroll, F. Ivy
    Roth, Bryan L.
    Cohen, Bruce M.
    Carlezon, William A., Jr.
    PSYCHOPHARMACOLOGY, 2010, 210 (02) : 263 - 274
  • [46] Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
    Butelman, Eduardo R.
    Kreek, Mary Jeanne
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [47] Ligand-based approach for the identification of novel ligands:: Application to Salvinorin A, a selective kappa opioid receptor (KOP) agonist
    Singh, Nidhi
    Cheve, Gwenael
    Narayanan, Sanju
    McCurdy, Christopher R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [48] Antagonistic property of buprenorphine for ε-opioid receptor.
    Mizoguchi, H
    Wu, HE
    Spaulding, A
    Narita, M
    Hall, FS
    Sora, I
    Uhl, GR
    Nagase, H
    Tseng, LF
    Sakurada, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 218P - 218P
  • [49] Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets
    Wang, Zhenhong
    Ma, Nan
    Riley, John
    Armstead, William M.
    Liu, Renyu
    PLOS ONE, 2012, 7 (07):
  • [50] Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study
    Saleh, Amr H.
    Abdelwaly, Ahmad
    Darwish, Khaled M.
    Eissa, Amal A. H. M.
    Chittiboyina, Amar
    Helal, Mohamed A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2021, 106
12345